The US food and medicine administration encourages the covid vaccine two doses of Pfizer-Biontech on Monday, further accelerating the previous timeline to license shots, according to people who are familiar with agency planning.
Regulators work to complete the process on Friday but still work through a large number of documents and talks with the company.
People who are familiar with planning warn that the agreement can slide beyond Monday if some of the review components require more time.
A FDA spokesman did not comment.
The agency previously set an unofficial deadline for the approval of September 6 is expected to pave the way for a series of vaccination requirements by public and private organizations that await the final regulations before implementing the mandate.
Officials also hope that the approved shot will attract interest from people who are hesitant to take it, a phenomenon suggested by recent voting.